n-methyl-3,4-methylenedioxyamphetamine has been researched along with methylphenidate in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (4.00) | 18.2507 |
2000's | 8 (32.00) | 29.6817 |
2010's | 13 (52.00) | 24.3611 |
2020's | 3 (12.00) | 2.80 |
Authors | Studies |
---|---|
Durst, R; Rebaudengo-Rosca, P | 1 |
Achat-Mendes, C; Anderson, KL; Itzhak, Y | 1 |
Kishimoto, H | 1 |
Kuypers, KP; Ramaekers, JG | 1 |
Kuypers, KP; Ramaekers, JG; Samyn, N | 1 |
Ikeda, K; Iwamura, T; Kobayashi, T; Nishizawa, D | 1 |
Fahey, MA; Fryer, AK; Lynch, L; Madras, BK; Miller, GM; Verrico, CD | 1 |
Collier, TJ; Lipton, JW; Lynch, KA; Paumier, KL; Pei, L; Sortwell, CE; Terpstra, BT; Thompson, VB; Tolod, EG | 1 |
Cerutti, DT; Galizio, M; McKinney, P; Pitts, RC | 1 |
Arrant, AE; Caster, JM; Kuhn, CM; Morris, SE; Nagel, JM; Parylak, S; Walker, QD; Zhou, G | 1 |
Atkins, KD; Dafny, N; Yang, PB | 1 |
Costa, G; Fenu, S; Morelli, M; Pinna, A; Plumitallo, A; Simola, N | 1 |
Donzelli, M; Grouzmann, E; Hysek, CM; Liechti, ME; Meyer, N; Schillinger, N; Schmid, Y; Simmler, LD | 1 |
Hysek, CM; Kratschmar, DV; Liechti, ME; Odermatt, A; Penno, CA; Schmid, Y; Seibert, J | 1 |
Higashiyama, K; Kazawa, H; Mochizuki, A; Mori, T; Shibasaki, M; Suzuki, T; Uzawa, N; Watanabe, H; Yoshizawa, K | 1 |
Crockett, MJ; Hysek, CM; Liechti, ME; Quednow, BB; Schmid, Y; Simmler, LD | 1 |
Bilderbeck, AC; Bosch, OG; Hysek, CM; Liechti, ME; Preller, KH; Quednow, BB; Rogers, RD; Schmid, Y | 1 |
Eggleston, W; Stork, C | 1 |
Borgwardt, S; Dolder, PC; Liechti, ME; Müller, F; Schmid, Y; Schmidt, A; Zanchi, D | 1 |
Borgwardt, SJ; Dolder, PC; Liechti, ME; Müller, F; Schmid, Y | 1 |
Borgwardt, S; Dolder, PC; Egloff, L; Liechti, ME; Müller, F; Schmid, Y; Schmidt, A; Zanchi, D | 1 |
Johansen, SS; Linnet, K; Nedahl, M | 1 |
Hirayama, S; Hokazono, M; Iwase, Y; Masukawa, D; Mori, T; Suzuki, T; Udagawa, Y; Uzawa, N | 1 |
Daviskiba, S; Dean, D; Kern, P; King, A; Reed, B; Rockhill, S; Vohra, V | 1 |
Baumgartner, MR; Fischer, SKM; Müller, TJ; Mutschler, J; Perlov, E; Seifritz, E; Soyka, M; Tschudi, L | 1 |
2 review(s) available for n-methyl-3,4-methylenedioxyamphetamine and methylphenidate
Article | Year |
---|---|
[Stimulant dependence].
Topics: Amphetamine-Related Disorders; Antipsychotic Agents; Central Nervous System Stimulants; Humans; Methamphetamine; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Self-Help Groups; Social Support | 2003 |
Generation Z: Adolescent Xenobiotic Abuse in the 21st Century.
Topics: Adolescent; Amphetamine-Related Disorders; Cannabinoids; Central Nervous System Stimulants; Designer Drugs; Dextroamphetamine; Dextromethorphan; Excitatory Amino Acid Antagonists; Hallucinogens; Humans; Inhalant Abuse; Ketamine; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine Abuse; Receptors, N-Methyl-D-Aspartate; Substance-Related Disorders; Xenobiotics | 2015 |
9 trial(s) available for n-methyl-3,4-methylenedioxyamphetamine and methylphenidate
Article | Year |
---|---|
Transient memory impairment after acute dose of 75mg 3.4-Methylene-dioxymethamphetamine.
Topics: Adult; Affect; Amphetamine-Related Disorders; Cross-Over Studies; Discrimination Learning; Double-Blind Method; Female; Humans; Male; Memory; Memory, Short-Term; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Pattern Recognition, Visual; Problem Solving; Retention, Psychology; Substance Withdrawal Syndrome; Verbal Learning | 2005 |
Stimulant effects of 3,4-methylenedioxymethamphetamine (MDMA) 75 mg and methylphenidate 20 mg on actual driving during intoxication and withdrawal.
Topics: Adult; Amphetamine-Related Disorders; Automobile Driving; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Europe; Female; Hallucinogens; Humans; Male; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine | 2006 |
Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination.
Topics: Adult; Affect; Area Under Curve; Autonomic Nervous System; Central Nervous System Stimulants; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Endocrine System; Female; Hallucinogens; Humans; Male; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Young Adult | 2014 |
Acute effects of 3,4-methylenedioxymethamphetamine and methylphenidate on circulating steroid levels in healthy subjects.
Topics: Chromatography, Liquid; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Psychotropic Drugs; Steroids; Tandem Mass Spectrometry; Time Factors; Young Adult | 2014 |
Differential effects of MDMA and methylphenidate on social cognition.
Topics: Adolescent; Adult; Central Nervous System Stimulants; Cognition; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Emotions; Empathy; Epinephrine; Facial Expression; Female; Hallucinogens; Humans; Hydrocortisone; Judgment; Male; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Oxytocin; Prolactin; Recognition, Psychology; Young Adult | 2014 |
Effects of methylphenidate and MDMA on appraisal of erotic stimuli and intimate relationships.
Topics: Adolescent; Adult; Central Nervous System Stimulants; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Estradiol; Female; Hallucinogens; Humans; Interpersonal Relations; Libido; Male; Methylphenidate; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Progesterone; Sexual Behavior; Testosterone; Time Factors; Young Adult | 2015 |
Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects.
Topics: Benzhydryl Compounds; Brain; Brain Mapping; Central Nervous System Stimulants; Cognition; Cross-Over Studies; Double-Blind Method; Emotions; Female; Hallucinogens; Healthy Volunteers; Humans; Image Processing, Computer-Assisted; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Methylphenidate; Modafinil; N-Methyl-3,4-methylenedioxyamphetamine; Neural Pathways; Oxygen; Psychometrics | 2017 |
Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects.
Topics: Adult; Arousal; Autonomic Nervous System; Central Nervous System Stimulants; Cross-Over Studies; Double-Blind Method; Emotions; Facial Recognition; Female; Hallucinogens; Healthy Volunteers; Humans; Libido; Male; Methylphenidate; Modafinil; N-Methyl-3,4-methylenedioxyamphetamine; Sexual Behavior; Young Adult | 2018 |
Acute Effects of Methylphenidate, Modafinil, and MDMA on Negative Emotion Processing.
Topics: Adult; Brain; Central Nervous System Stimulants; Cross-Over Studies; Double-Blind Method; Facial Expression; Facial Recognition; Fear; Female; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Male; Methylphenidate; Modafinil; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Agents; Young Adult | 2018 |
14 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and methylphenidate
Article | Year |
---|---|
[Attention deficit hyperactivity disorder, facilitating alcohol and drug abuse in an adult].
Topics: Adult; Alcoholism; Attention Deficit Disorder with Hyperactivity; Cannabis; Central Nervous System Stimulants; Female; Humans; Lysergic Acid Diethylamide; Marijuana Abuse; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders | 1997 |
Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood.
Topics: Age Factors; Animals; Central Nervous System Stimulants; Cocaine; Conditioning, Psychological; Male; Methylphenidate; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Psychomotor Performance; Reward; Substance Withdrawal Syndrome; Time Factors; Weight Gain | 2003 |
Inhibition by cocaine of G protein-activated inwardly rectifying K+ channels expressed in Xenopus oocytes.
Topics: Animals; Brain Chemistry; Central Nervous System Stimulants; Cocaine; Dose-Response Relationship, Drug; Electrophysiology; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Heart; Methamphetamine; Methylphenidate; Mice; Myocardium; N-Methyl-3,4-methylenedioxyamphetamine; Plasmids; Potassium Channel Blockers; RNA, Messenger; Xenopus laevis | 2007 |
MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor.
Topics: Administration, Oral; Animals; Appetitive Behavior; Association Learning; Cell Line; Citalopram; Desipramine; Discrimination Learning; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Injections, Intramuscular; Macaca fascicularis; Male; Mental Recall; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine Plasma Membrane Transport Proteins; Reversal Learning; Serotonin Plasma Membrane Transport Proteins; Stereotyped Behavior | 2008 |
3,4-Methylenedioxy-N-methamphetamine (ecstasy) promotes the survival of fetal dopamine neurons in culture.
Topics: Analysis of Variance; Animals; Animals, Newborn; Cell Survival; Cells, Cultured; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Embryo, Mammalian; Female; Gene Expression Regulation; Hallucinogens; In Vitro Techniques; Male; Mesencephalon; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Neurites; Neurons; Pregnancy; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 2008 |
Effects of MDMA, methamphetamine and methylphenidate on repeated acquisition and performance in rats.
Topics: Animals; Dose-Response Relationship, Drug; Male; Methamphetamine; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reaction Time; Reinforcement Schedule; Time Factors | 2009 |
Dopamine uptake inhibitors but not dopamine releasers induce greater increases in motor behavior and extracellular dopamine in adolescent rats than in adult male rats.
Topics: Aging; Amphetamines; Animals; Behavior, Animal; Brain Chemistry; Dopamine; Dopamine Uptake Inhibitors; Electrophysiology; Male; Methylphenidate; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Neostriatum; Nomifensine; Piperazines; Rats; Rats, Sprague-Dawley | 2010 |
Behavioral sensitization and cross-sensitization between methylphenidate amphetamine, and 3,4-methylenedioxymethamphetamine (MDMA) in female SD rats.
Topics: Animals; Behavior, Animal; Drug Interactions; Drug Tolerance; Female; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Time Factors | 2011 |
Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward.
Topics: Animals; Central Nervous System Stimulants; Male; Methylphenidate; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Psychotropic Drugs; Rats; Rats, Sprague-Dawley; Reward; Vocalization, Animal | 2012 |
Differential substitution for the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and methylphenidate in rats.
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Discrimination Learning; Dose-Response Relationship, Drug; Male; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred F344; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT2; Receptors, sigma; Sigma-1 Receptor | 2014 |
Postmortem Brain-Blood Ratios of Amphetamine, Cocaine, Ephedrine, MDMA and Methylphenidate.
Topics: Amphetamine; Autopsy; Brain Chemistry; Calibration; Cocaine; Forensic Toxicology; Gray Matter; Humans; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Postmortem Changes; Reference Standards; Reproducibility of Results | 2019 |
Enhancement of the rewarding effects of 3,4-methylenedioxymethamphetamine in orexin knockout mice.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Classical; Gyrus Cinguli; Male; Methamphetamine; Methylphenidate; Mice; Mice, Inbred C57BL; Mice, Knockout; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Orexins; Reward; Serotonin 5-HT1 Receptor Agonists; Spatial Learning | 2021 |
Stimulant storm - state health department psychostimulant age-adjusted mortality rate correlates with psychostimulant-based Michigan Poison Center case exposures over time.
Topics: Adult; Amphetamine; Central Nervous System Stimulants; Dextroamphetamine; Drug Overdose; Female; Humans; Linear Models; Male; Methamphetamine; Methylphenidate; Michigan; N-Methyl-3,4-methylenedioxyamphetamine; Opioid-Related Disorders; Poison Control Centers | 2021 |
Concomitant Drug Use among Opioid-Dependent Patients with and without Attention Deficit Hyperactivity Disorder: Does Methylphenidate Merit a Trial?
Topics: Amphetamine; Analgesics, Opioid; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Cross-Sectional Studies; Heroin; Humans; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders; Treatment Outcome | 2023 |